Welcome
Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 22,500 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.
|
| NEWS | CONGRESSES |
|---|---|
December 02, 2011Fresenius Kabi announces Changes in the Management Board PDF-Download (22 KBytes) 
November 02, 2011 Fresenius achieves record Q3 earnings − improves 2011 earnings outlook PDF-Download (155 KBytes)
September 26, 2011 Fresenius opens new production facility in Vietnam PDF-Download (25 KBytes)
|
ISICEM March 20 - 23, 2012 Brussels, Belgium Come and visit us on our Fresenius Kabi booth at ISICEM Link to congress websiteEAHP March 21 - 23, 2012 Milan, Italy Come and visit us on our Fresenius Kabi booth at EAHP Link to congress websiteWCA March 25 - 30, 2012 Buenos Aires, Argentina We are looking forward to welcome you on our booth at WCA Link to congress website |
| Overview News |
Overview Congresses |